Cvs Cooling Patch

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains of muscles and joints associated with conditions such as simple backache, arthritis, strains, bruises, and sprains.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Adults and children 12 years of age and older should first clean and dry the affected area before application. The protective film of the patch should be partially peeled back, allowing the exposed adhesive side to be applied directly to the site of pain. After positioning the patch, the remaining film must be carefully removed while pressing the patch firmly against the skin to ensure proper adhesion.

The patch may be used on the affected area no more than 3 to 4 times daily, with one patch applied per application. After use, the patch should be discarded appropriately. Unused patches should be stored by resealing the pouch immediately after opening.

For children under 12 years of age, it is advised to consult a physician prior to use. Healthcare professionals should also instruct patients to wash their hands with cool water after handling the patch to maintain hygiene.

Contraindications

Use of this product is contraindicated in the following situations:

Application is prohibited on wounds, damaged, or irritated skin due to the risk of exacerbating the condition or causing further irritation. Additionally, the use of a heating pad in conjunction with this product is contraindicated, as it may lead to increased irritation or adverse effects.

Patients with known allergies to any ingredients in this product should not use it, as this may result in allergic reactions.

Warnings and Precautions

For external use only. This product is contraindicated for application on wounds or damaged skin and should not be used in conjunction with a heating pad. Individuals with known allergies to any of the ingredients in this product should refrain from use.

Healthcare professionals should advise patients to discontinue use and seek medical attention if any of the following occur: worsening of the condition, persistence of symptoms beyond 7 days, recurrence of symptoms after initial improvement within a few days, presence of redness, development of irritation, or if symptoms related to arthritis persist for more than 10 days.

It is imperative to keep this product out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Side Effects

Patients using this product may experience a range of adverse reactions. It is important to note that this product is for external use only and should not be applied to wounds or damaged skin. Additionally, patients should avoid using this product in conjunction with a heating pad.

During the use of this product, patients are advised to avoid contact with the eyes and mucous membranes. Application to irritated skin or areas where excessive irritation develops should also be avoided. Furthermore, patients should not bandage the area tightly or use the product with a heating pad. Thorough hand washing after application is recommended to prevent unintended exposure.

Patients should discontinue use and consult a healthcare professional if any of the following occur: the condition worsens, symptoms persist for more than 7 days, symptoms resolve and then recur within a few days, redness is present, irritation develops, or if symptoms persist for more than 10 days in the case of arthritis.

In the event of accidental ingestion, patients should seek medical assistance or contact a Poison Control Center immediately.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Cvs Cooling Patch (menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 12 years of age should consult a physician prior to use. For adolescents aged 12 years and older, the recommended application involves cleaning and drying the affected area, then partially peeling back the protective film to apply the exposed patch to the site of pain. The remaining film should be carefully removed while pressing the patch firmly onto the skin. Each patch should be used on the affected area no more than 3 to 4 times daily, with only one patch applied per application.

It is essential to keep the product out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought or contact with a Poison Control Center is advised.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. It is important to assess the potential risks and benefits, as well as any available data regarding fetal outcomes and lactation. Healthcare providers can offer guidance tailored to individual circumstances, ensuring the safety of both the patient and the developing fetus or nursing infant.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data regarding the excretion of this medication in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating mothers.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the drug insert regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to patients with reduced kidney function, as the lack of data necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in these patients, although specific recommendations are not provided.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the event of an overdosage, immediate medical intervention is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical assistance or contact a Poison Control Center without delay.

Prompt action is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved; therefore, a thorough assessment by a medical professional is recommended to determine the appropriate course of action.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. Continuous monitoring and evaluation are advised to ensure patient safety and effective management of any complications that may arise from the overdosage.

Nonclinical Toxicology

If pregnant or breastfeeding, it is advised to consult a health professional prior to use. There are no specific non-teratogenic effects or detailed nonclinical toxicology findings available. Additionally, no specific information regarding animal pharmacology and toxicology has been provided.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children. Instruct patients that if the product is swallowed, they should seek medical help or contact a Poison Control Center immediately.

Patients should be informed not to use the product on wounds or damaged skin and to avoid using it in conjunction with a heating pad. It is essential to ensure that patients are aware of any allergies they may have to the ingredients of this product, as it should not be used if they are allergic.

Healthcare providers should counsel patients to stop using the product and consult a doctor if any of the following occur: the condition worsens, symptoms persist for more than 7 days, symptoms clear up and then recur within a few days, redness is present, irritation develops, or if symptoms persist for more than 10 days in the case of arthritis.

When using this product, patients should be instructed to use it only as directed and to avoid contact with the eyes and mucous membranes. They should not apply the product to wounds, damaged skin, or irritated skin, and should refrain from bandaging tightly or using it with a heating pad. Additionally, patients should wash their hands thoroughly after application to prevent unintended exposure.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at room temperature, ensuring that the temperature does not exceed 86°F (30°C). The storage location should be a cool, dry place, and the product must be kept away from direct sunlight to maintain its integrity. Proper handling and storage conditions are crucial for preserving the quality of the product.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Cvs Cooling Patch, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)